Who owns VERTEX PHARMACEUTICALS INC / MA (VRTX)? Elite investor 13F holders
7 tracked elite investors reported holding VERTEX PHARMACEUTICALS INC / MA as of 2026-09-30, including Renaissance Technologies LLC, Tweedy Browne, Bridgewater Associates, Gotham Asset Management, D.E. Shaw. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
7 tracked investors currently reported holding · Latest report period: 2026-09-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally. The company offers transformative medicines for people with serious diseases with a focus on specialty markets, such as cystic fibrosis (CF), sickle cell disease (SCD), transfusion dependent beta thalassemia (TDT), and acute pain. It markets TRIKAFTA/KAFTRIO for people with…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Renaissance Technologies LLC | VERTEX PHARMACEUTICALS INC | SHARE | 2026-09-30 | 2026-11-12 00:00:00 | 207434278.00 USD | 396768.000000 | Shares | add | Original filing |
| Tweedy Browne | VERTEX PHARMACEUTICALS INC | SHARE | 2026-09-30 | 2026-11-04 00:00:00 | 13599857.00 USD | 26013.000000 | Shares | reduce | Original filing |
| Bridgewater Associates | VERTEX PHARMACEUTICALS INC | SHARE | 2026-09-30 | 2026-11-16 00:00:00 | 18253911.00 USD | 34915.000000 | Shares | add | Original filing |
| Gotham Asset Management | VERTEX PHARMACEUTICALS INC | SHARE | 2026-09-30 | 2026-11-16 00:00:00 | 17391797.00 USD | 33266.000000 | Shares | add | Original filing |
| Torray Funds | VERTEX PHARMACEUTICALS INC | SHARE | 2026-09-30 | 2026-10-30 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | Original filing |
| D.E. Shaw | VERTEX PHARMACEUTICALS INC | SHARE | 2026-09-30 | 2026-11-16 00:00:00 | 2943944.00 USD | 5631.000000 | Shares | add | Original filing |
| Ancora Advisors / Ancora Holdings | VERTEX PHARMACEUTICALS INC | SHARE | 2026-09-30 | 2026-11-17 00:00:00 | 658393.00 USD | 1259.000000 | Shares | add | Original filing |
| GAMCO | VERTEX PHARMACEUTICALS INC | SHARE | 2026-09-30 | 2026-11-12 00:00:00 | 209124.00 USD | 400.000000 | Shares | buy | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.